Position in RLMD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$619,111
+$329,311 QoQ
Shares Held
88,953
+48.3% QoQ
Ownership
0.085%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
16 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RLMD Over Time
Shares Held
Position Value (USD)
Derivatives in RLMD
reported options exposure · as of Dec 31, 2022CallValue
$0
CallShares
0
PutValue
$7,329
PutShares
2,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BARCLAYS PLC holds $1,494,072,071 across 362 Biotechnology names. RLMD ranks #136 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
663,263 | $296,173,457 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
313,093 | $241,908,173 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
220,623 | $72,997,531 | |
| 4 | MRNA |
Moderna, Inc.
|
932,269 | $47,359,264 | |
| 5 | INSM |
INSMED Inc
|
275,731 | $45,087,531 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
1,415,848 | $39,218,988 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
383,179 | $37,264,156 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
669,601 | $35,301,364 |
All Filings in RLMD
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $619,111 | 88,953 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $289,800 | 60,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $20,100 | 10,000 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $0 | 1 | Shares | Sole | 2026-02-27 | |
| 2024-12-31 | $75,919 | 145,999 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $473,036 | 145,999 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $437,997 | 145,999 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $678,895 | 145,999 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $604,435 | 145,999 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $437,997 | 145,999 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $359,157 | 145,999 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $33,533 | 14,838 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $32,899 | 9,427 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $7,329 | 2,100 | Put | Sole | 2026-03-30 | |
| 2022-09-30 | $262,879 | 7,101 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $317,113 | 16,699 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $45,883 | 1,700 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||